Literature DB >> 8560775

Molecular analysis of human T-cell lymphotropic virus type II from Wayuu Indians of Colombia demonstrates two subtypes of HTLV-IIb.

W M Switzer1, S M Owen, D A Pieniazek, V R Nerurkar, E Duenas-Barajas, W Heneine, R B Lal.   

Abstract

Studies of the genetic heterogeneity of human T-cell lymphotropic virus type II (HTLV-II) have revealed the presence of two genetic subtypes, termed HTLV-IIa and HTLV-IIb. The HTLV-IIb subtype encodes an immunodominant epitope present at the C-terminus of the extended Tax protein and, by using an LTR-based, restriction fragment-length polymorphism (RFLP) assay, can be further classified into IIb60-IIb5, with HTLV-IIb1 (Central Amerindian-like) and HTLV-IIb5 (North Amerindian-like) being characteristic subtypes for Native American Indians. To determine the antigenic and genetic heterogeneity among HTLV-II-infected South Amerindians, we used a Tax synthetic peptide immunoassay on serum, and RFLP and phylogenetic analysis on LTR sequences amplified from genomic DNA from four Wayuu Indians of Colombia. The Wayuu specimens displayed seroreactivity to the immunodominant epitope located in the extended Tax region, as predicted, and demonstrated genetic heterogeneity by the presence of both the IIB1 (Wyu1, Zuc31) and IIb5 (Wyu2, Zuc42) subtypes sequences within separate phylogroups represented by the Guaymi Indian (IIb1) and North Amerindian (IIb5) sequences, respectively. Sequence analysis showed that major LTR regulatory motifs and the cis-acting repressive elements in the LTR RNA secondary structure were relatively conserved in both Wayuu subtypes, but the predicted secondary structure of the rex response stem loop in the Wyu2 (IIb5) LTR sequence was 45 nucleotides (nt) and 95 nt longer than that observed in the Wyu1 (IIb1) and G12.1 (IIb1) LTR sequences, respectively. These results extend our knowledge of the genetic heterogeneity of HTLV-II in South Amerindians.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8560775     DOI: 10.1007/bf01702596

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  31 in total

1.  Native American mitochondrial DNA analysis indicates that the Amerind and the Nadene populations were founded by two independent migrations.

Authors:  A Torroni; T G Schurr; C C Yang; E J Szathmary; R C Williams; M S Schanfield; G A Troup; W C Knowler; D N Lawrence; K M Weiss
Journal:  Genetics       Date:  1992-01       Impact factor: 4.562

2.  Sensitive and specific polymerase chain reaction assays for diagnosis of human T-cell lymphotropic virus type I (HTLV-I) and HTLV-II infections in HTLV-I/II-seropositive individuals.

Authors:  W Heneine; R F Khabbaz; R B Lal; J E Kaplan
Journal:  J Clin Microbiol       Date:  1992-06       Impact factor: 5.948

Review 3.  The epidemiology of the human T-cell lymphotrophic virus type I and type II: etiologic role in human disease.

Authors:  A Manns; W A Blattner
Journal:  Transfusion       Date:  1991-01       Impact factor: 3.157

4.  Complete nucleotide sequence of an infectious clone of human T-cell leukemia virus type II: an open reading frame for the protease gene.

Authors:  K Shimotohno; Y Takahashi; N Shimizu; T Gojobori; D W Golde; I S Chen; M Miwa; T Sugimura
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

5.  HTLV-II infection in Florida Indians.

Authors:  P H Levine; S Jacobson; R Elliott; A Cavallero; G Colclough; C Dorry; C Stephenson; R M Knigge; J Drummond; M Nishimura
Journal:  AIDS Res Hum Retroviruses       Date:  1993-02       Impact factor: 2.205

6.  Molecular characterization of two isolates of human T cell leukaemia virus type II from Italian drug abusers and comparison of genome structure with other isolates.

Authors:  D Zella; A Cavicchini; M Salemi; C Casoli; F Lori; G Achilli; E Cattaneo; V Landini; U Bertazzoni
Journal:  J Gen Virol       Date:  1993-03       Impact factor: 3.891

7.  HTLV-II seroprevalence in pygmies across Africa since 1970.

Authors:  P Goubau; H F Liu; G G De Lange; A M Vandamme; J Desmyter
Journal:  AIDS Res Hum Retroviruses       Date:  1993-08       Impact factor: 2.205

8.  Human retroviruses in Amerindians of Colombia: high prevalence of human T cell lymphotropic virus type II infection among the Tunebo Indians.

Authors:  E Duenas-Barajas; J E Bernal; D R Vaught; V R Nerurkar; P Sarmiento; R Yanagihara; D C Gajdusek
Journal:  Am J Trop Med Hyg       Date:  1993-12       Impact factor: 2.345

9.  Genetic heterogeneity in human T-cell leukemia/lymphoma virus type II.

Authors:  D K Dube; M P Sherman; N K Saksena; V Bryz-Gornia; J Mendelson; J Love; C B Arnold; T Spicer; S Dube; J B Glaser
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

10.  Phylogenetic relationship and geographic distribution of multiple human T-cell lymphotropic virus type II subtypes.

Authors:  W M Switzer; D Pieniazek; P Swanson; H H Samdal; V Soriano; R F Khabbaz; J E Kaplan; R B Lal; W Heneine
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

View more
  11 in total

1.  Molecular evidence for infection by HTLV-2 among individuals with negative serological screening tests for HTLV antibodies.

Authors:  R Ishak; A C R Vallinoto; V N Azevedo; A C P Vicente; W W Hall; M O G Ishak
Journal:  Epidemiol Infect       Date:  2006-09-07       Impact factor: 2.451

2.  African origin of human T-lymphotropic virus type 2 (HTLV-2) supported by a potential new HTLV-2d subtype in Congolese Bambuti Efe Pygmies.

Authors:  A M Vandamme; M Salemi; M Van Brussel; H F Liu; K Van Laethem; M Van Ranst; L Michels; J Desmyter; P Goubau
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

Review 3.  The origin and evolution of human T-cell lymphotropic virus types I and II.

Authors:  Y Suzuki; T Gojobori
Journal:  Virus Genes       Date:  1998       Impact factor: 2.332

4.  Different population dynamics of human T cell lymphotropic virus type II in intravenous drug users compared with endemically infected tribes.

Authors:  M Salemi; M Lewis; J F Egan; W W Hall; J Desmyter; A M Vandamme
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

5.  Differences in the ability of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 tax to inhibit p53 function.

Authors:  R Mahieux; C A Pise-Masison; P F Lambert; C Nicot; L De Marchis; A Gessain; P Green; W Hall; J N Brady
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

6.  The simian T-lymphotropic/leukemia virus from Pan paniscus belongs to the type 2 family and infects Asian macaques.

Authors:  L Digilio; A Giri; N Cho; J Slattery; P Markham; G Franchini
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

7.  Identification and characterization of a new and distinct molecular subtype of human T-cell lymphotropic virus type 2.

Authors:  N Eiraku; P Novoa; M da Costa Ferreira; C Monken; R Ishak; O da Costa Ferreira; S W Zhu; R Lorenco; M Ishak; V Azvedo; J Guerreiro; M P de Oliveira; P Loureiro; N Hammerschlak; S Ijichi; W M Hall
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

8.  High seroprevalence of human T-cell lymphotropic virus type 1 in blood donors in Guyana and molecular and phylogenetic analysis of new strains in the Guyana shelf (Guyana, Suriname, and French Guiana).

Authors:  Jean-François Pouliquen; Lynette Hardy; Anne Lavergne; Eric Kafiludine; Mirdad Kazanji
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

9.  Enhanced specificity of truncated transmembrane protein for serologic confirmation of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 infections by western blot (immunoblot) assay containing recombinant envelope glycoproteins.

Authors:  M Varma; D L Rudolph; M Knuchel; W M Switzer; K G Hadlock; M Velligan; L Chan; S K Foung; R B Lal
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

Review 10.  Infectious Agents As Markers of Human Migration toward the Amazon Region of Brazil.

Authors:  Ricardo Ishak; Luiz F A Machado; Izaura Cayres-Vallinoto; Marluísa de O Guimarães Ishak; Antonio C R Vallinoto
Journal:  Front Microbiol       Date:  2017-08-31       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.